º¬Ðß²ÝÉçÇø

Introduction

Stephanie Wang is of counsel at Global Law Office, based in Shanghai. Her expertise lies in the life sciences and healthcare sector, where she focuses her practice on M&A, cross-border licensing, private equity and compliance. She advises a diverse range of pharmaceutical, biotech and medical device companies, from multinational corporations to state-owned, private and emerging enterprises. These include GSK, Sanofi, Abbott, Zeiss, Siemens, Johnson & Johnson, Ipsen, BeiGene, Shanghai Pharmaceuticals, CR Pharma, Hisun Pharma, Baheal Pharma and Dongbao Pharma.

Wang specialises in transactions and regulatory compliance, advising clients on investment, M&A, joint R&D, licensing and commercialisation, asset acquisition and divestiture, foreign investment, outbound investment, product commercialisation, as well as pharmaceutical advertising and promotion.

In cross-border investment and local operations support, Wang provides clients with constructive and actionable legal advice, helping them navigate an increasingly complex regulatory environment. She has assisted a major state-owned pharmaceutical enterprise in expanding its R&D pipeline and building production facilities in emerging markets, handling transaction structuring, governance frameworks, domestic regulatory approvals and overseas compliance.

In corporate compliance and risk control, Wang specialises in compliance risk assessment and supports clients in implementing pre-emptive remediation measures. She has guided numerous pharmaceutical companies through proactive compliance remediation ahead of National Healthcare Security Administration credit evaluations, helping them avoid potential credit downgrades.

In private equity, Wang has worked with leading PE firms, advising on legal due diligence, transaction structuring, the drafting and negotiation of investment agreements, and project closings. She excels in delivering practical solutions across diverse legal scenarios.

Wang has been listed as a recommended lawyer in the life sciences and healthcare as well as compliance and regulatory sectors by The Legal 500.